MetaCap

SIGA Technologies Inc. (SIGA)

NASDAQ: SIGAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.40-0.25 (-9.43%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

SIGA stock chart

Technical analysis

Key statistics

All statistics
Market cap
$172.45M
P/E (TTM)
240.00
Ex-dividend date
Apr 7, 2026
52-week range
2.30 – 7.11
Day range
2.30 – 2.65
Volume / Avg
788.24K / 617.60K
Beta
—

52-week range

$2.30$7.11

SIGA stock today

Shares of SIGA Technologies (SIGA) finished lower on Nov 20 at $2.40, a drop of 9.43% or $0.25 per share, versus the S&P 500's 3.70% decline. At this level, SIGA sits near the bottom of its 52-week range of $2.30 to $7.11: 66.2% below the high, set on Feb 3, 2026 and 4.3% above the low. SIGA is down 60.7% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 58.9%.

SIGA Technologies trades at 240.0x its trailing twelve-month earnings per share of $0.01. Its forward P/E of 5.5x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About SIGA Technologies

Company profile

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Dr. Diem Nguyen M.B.A., Ph.D.
Headquarters
New York, NY
Employees
49
Website
siga.com

Financial highlights

Full financials

In fiscal 2025, SIGA Technologies generated $94.6 million in revenue, down 31.8% from fiscal 2024, its first annual decline since 2024. Net income was $23.3 million (-60.7% year over year), for a net margin of 24.6% versus a median of 45.1% in the prior 5 years. Gross margin was 68.6% (down from 77.4%) and operating margin 25.1%.

SIGA Technologies annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$94.57M$138.72M$139.92M$110.78M$133.67M
Growth-31.82%-0.86%+26.31%-17.13%+6.97%
Net income$23.28M$59.21M$68.07M$33.90M$69.45M
EPS (diluted)$0.32$0.82$0.95$0.46$0.91

Analyst forecast

Forecast

Consensus (1 analysts)

strong_buy

Avg. price target

$3.25+35.42%

  • Strong buy 0
  • Buy 1
  • Hold 0
  • Sell 0
  • Strong sell 0

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 9, 2026
EPS actual vs est.
$-0.09 vs —

Dividends

Dividend history
Annual dividend
$0.00
Last payment
$0.60
Ex-dividend date
Apr 7, 2026

SIGA news

All SIGA news

SIGA Technologies peers

Health Care sector
SIGA peer companies
CompanyPrice% ChgMarket capCompare
TRDAEntrada Therapeutics Inc.4.35-6.25%$170.30Mvs SIGA
VOGXVogenx Inc11.87-7.30%$176.33Mvs SIGA
NATRNature's Sunshine Products Inc.10.18+0.10%$176.41Mvs SIGA
KRROKorro Bio Inc.12.18-0.08%$167.18Mvs SIGA
ABEOAbeona Therapeutics Inc.2.42-1.22%$165.31Mvs SIGA
ADCTADC Therapeutics SA1.28-1.54%$180.05Mvs SIGA
SLGLSol-Gel Technologies Ltd.55.17+2.02%$180.63Mvs SIGA
WHWKWhitehawk Therapeutics Inc.3.07-1.60%$181.16Mvs SIGA

Indexes, lists and sector

SIGA Technologies stock FAQ

What is SIGA Technologies's stock price today?

SIGA last traded at $2.40 as of Nov 20, 4:00 PM EST, down 9.43% on the day. Prices are delayed at least 15 minutes.

Does SIGA Technologies pay a dividend?

Yes. SIGA Technologies pays $0.00 per share annually. The most recent dividend of $0.60 had an ex-dividend date of Apr 7, 2026.

What is SIGA's P/E ratio?

SIGA trades at a trailing P/E ratio of 240.00 and a forward P/E of 5.45.

Who is SIGA Technologies's CEO?

Dr. Diem Nguyen M.B.A., Ph.D. is the chief executive officer of SIGA Technologies Inc., which has about 49 employees.

What is the SIGA 52-week high?

The 52-week high for SIGA is $7.11 and the 52-week low is $2.30. The stock is currently 66.2% below its high.

Compare SIGA